open
serve
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
News
Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Ask Genius
Apps
IJR News — today's news from every side
Ask Genius
Apps
Trending
Novartis MS pill beats Aubagio in two large phase 3 trials
x/novartis
— 1d
Novartis reported positive Phase 3 REMODEL-1 and REMODEL-2 results for the BTK inhibitor remibrutinib in relapsing multiple sclerosis, showing lower annualized relapse rate and meaningful reductions in disability progression versus teriflunomide and prompting worldwide regulatory filings. With remibrutinib already approved for chronic spontaneous urticaria as Rhapsido, the drug’s MS potential could become a major growth driver given its favorable safety profile and strong early sales signals.
+6
2
Share
Rachel Meyers
Teriflunomide isn't the toughest comparator out there, would like to see how remibrutinib stacks up against some of the stronger existing MS drugs before getting too excited.
Novartis Plans 140 Billion Won RLT Hub in Korea
Business
— Jul 21, 2026
Novartis will invest about 140 billion won to build Korea’s domestic radioligand therapy ecosystem, including local manufacturing, advanced cold-chain logistics, and a plan to train RLT specialists while expanding treatment sites from 10 to 30 hospitals. In partnership with the Ministry of Health and Welfare, the move aims to boost Korea’s RLT research, development, and manufacturing capabilities and improve access for cancer patients.
+3
Share
European stocks rise as oil lifts energy shares
Finance
— Jul 21, 2026
European shares edged higher as tech and AI-linked gains supported markets, with indices like the STOXX 600 and Euro STOXX 50 advancing while oil prices eased on U.S.-Iran mediation hopes amid the Yemen blockade. Gains were led by chipmakers such as ASML, ASMI and Infineon, with banks and Novartis also boosting sentiment ahead of upcoming earnings reports.
+21
Share
Video
— YouTube
VERDICT WATCH: MA v. Lindsay Clancy - Day 26 | Accused Killer Mom Trial
COURT TV · 1.6M views · Sep 2, 2026
8:46:53
XY Capital Expands Holdings Across Global Stocks
x/infosys
— Jul 22, 2026
XY Capital Ltd disclosed new or increased positions across five companies in Q1: Novartis, Yum China, Infosys, MINISO Group Holding, and NIO, with specific share purchases ranging from roughly 8,770 to 444,350 shares and portfolio weights from about 2.7% to 8.8%. Yum China became XY Capital’s largest holding, while MINISO and NIO occupy mid-range positions as the firm expands its diversified equity exposure.
Share
IJR
Dem Senate Hopeful Backed Trans Prison Policy — Female Inmate Says Convicted Killer Threatened To Rape Her
Nicole Silverio · 4 min · 7h
